medline.ch Urologie-Nephrologie Tumoren BPH

	Fat Fraction Extracted from Whole-Body Magnetic Resonance (WB-MR) in Bone Metastatic Prostate Cancer: Intra- and Inter-Reader Agreement of Single-Slice and Volumetric Measurements. Tomography Agazzi GM, Di Meo N, Rondi P, Saeli C, Dalla Volta A, Vezzoli M, Berruti A, Borghesi A, Maroldi R, Ravanelli M, Farina D. PMID: 39058047 [PubMed - indexed for MEDLINE]
	Automated Liquid Handling Extraction and Rapid Quantification of Underivatized Amino Acids and Tryptophan Metabolites from Human Serum and Plasma Using Dual-Column U(H)PLC-MRM-MS and Its Application to Prostate Cancer Study. Metabolites Kipura T, Hotze M, Hofer A, Egger AS, Timpen LE, Opitz CA, Townsend PA, Gethings LA, Thedieck K, Kwiatkowski M. PMID: 39057693 [PubMed]
	MRI-Targeted Prostate Fusion Biopsy: What Are We Missing outside the Target? Implications for Treatment Planning. Curr Oncol Oderda M, Dematteis A, Calleris G, Diamand R, Gatti M, Marra G, Adans-Dester G, Al Salhi Y, Pastore A, Faletti R, Gontero P. PMID: 39057180 [PubMed - indexed for MEDLINE]
	Navigation-Based Telehealth Informed Decision-Making for Prostate Cancer Screening in Black Men. Curr Oncol Ba DM, Kayembe C, Littlejohn J, Van Scoy LJ, VanDyke E, Williams J, Katoch A, Shook NC, Zhang Y, Livelsberger C, McDonald AC, Muscat JE. PMID: 39057145 [PubMed - indexed for MEDLINE]
	Salvage High-Intensity Focused Ultrasound for Prostate Cancer after Radiation Failure: A Narrative Review. Curr Oncol Sobhani S, Dadabhoy A, Ghoreifi A, Lebastchi AH. PMID: 39057142 [PubMed - indexed for MEDLINE]
	Impact of the COVID-19 Pandemic on Prostate Cancer Diagnosis, Staging, and Treatment: A Population-Based Study in Northern Italy. Biology (Basel) Mangone L, Marinelli F, Bisceglia I, Filice A, Braghiroli MB, Roncaglia F, Palicelli A, Morabito F, Neri A, Sabbatini R, Iotti C, Pinto C. PMID: 39056693 [PubMed]
	Metabolomic landscape of renal cell carcinoma in von Hippel-Lindau syndrome in a Chinese cohort. iScience Zhang Z, Wang Y, Yang W, Liu T, Wang C, Huang C, Xu Y, Chen X, Zhou J, Wang Y, Zhou X, Gong Y, Gong K. PMID: 39055909 [PubMed]
	Prognostic significance of soluble PD-L1 in prostate cancer. Front Immunol Zvirble M, Survila Z, Bosas P, Dobrovolskiene N, Mlynska A, Zaleskis G, Jursenaite J, Characiejus D, Pasukoniene V. PMID: 39055716 [PubMed - indexed for MEDLINE]
	Role of actin-binding proteins in prostate cancer. Front Cell Dev Biol Fu F, Yu Y, Zou B, Long Y, Wu L, Yin J, Zhou Q. PMID: 39055653 [PubMed]
	PSMA-based therapeutics for prostate cancer. Expert Opin Pharmacother Stamatakos PV, Fragkoulis C, Leventi A, Gklinos K, Kontolatis N, Papatsoris A, Dellis A. PMID: 39054909 [PubMed - as supplied by publisher]
	Development and validation of a predictive score for diagnosing prostate cancer in primary care. J Eval Clin Pract Lapi F, Marconi E, Cricelli I, Sobrero A, Salvetti A, Campo S, Cricelli C. PMID: 39054813 [PubMed - as supplied by publisher]
	Pattern, Clinical Characteristics, and Impact of Family History on Prostate-Specific Antigen in Prostate Cancer: A Multicenter Study. Am J Mens Health Iheanacho CO, Odili VU, Enakirerhi GE, Isiwele EM, Essiet A. PMID: 39054776 [PubMed - indexed for MEDLINE]
	Biparametric MRI of the prostate radiomics model for prediction of pelvic lymph node metastasis in prostate cancers : a two-centre study. BMC Med Imaging Li C, Hu J, Zhang Z, Wei C, Chen T, Wang X, Dai Y, Shen J. PMID: 39054441 [PubMed - indexed for MEDLINE]
	A randomized, open-label, phase 3 trial of pembrolizumab plus epacadostat versus sunitinib or pazopanib as first-line treatment for metastatic renal cell carcinoma (KEYNOTE-679/ECHO-302). BMC Cancer Lara PN Jr, Villanueva L, Ibanez C, Erman M, Lee JL, Heinrich D, Lipatov ON, Gedye C, Gokmen E, Acevedo A, Semenov A, Park SH, Gafanov RA, Kose F, Jones M, Du X, Munteanu M, Perini R, Choueiri TK, Motzer RJ. PMID: 39054430 [PubMed - indexed for MEDLINE]
	Re: Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial. Eur Urol Mancon S, Soria F, Pradere B, D'Andrea D. PMID: 39054191 [PubMed - as supplied by publisher]
	Online Group Cognitive Rehabilitation Program for Prostate Cancer Survivors: Development Using Codesign and the Theoretical Domains Framework. Semin Oncol Nurs Pembroke L, Sherman KA, Dhillon HM, Francis H, Gillatt D, Gurney H. PMID: 39054190 [PubMed - as supplied by publisher]
	Prostate cancer and the cell cycle: Focusing on the role of microRNAs. Gene Elazab IM, El-Feky OA, Khedr EG, El-Ashmawy NE. PMID: 39053658 [PubMed - as supplied by publisher]
	RNA modification Regulators' Co-Expression Score (RMRCoeS) predicts biochemical recurrence and therapy response in prostate cancer: A multi-omics and experimental validation study. Int Immunopharmacol Cai Z, Jiang Z, Li S, Mo S, Wang S, Liang M, Tan X, Zhong W, Zhang L, Deng J, Zhong C, Lu J. PMID: 39053228 [PubMed - as supplied by publisher]
	miR-371a-3p Predicting Viable Tumor in Patients Undergoing RPLND for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. J Urol Thor A, Myklebust MP, Bergdahl AG, Lundgren PO, Skokic V, Almås B, Haugnes HS, Tandstad T, Akre O, Cohn-Cedermark G, Dahl O, Kjellman A. PMID: 39052680 [PubMed - as supplied by publisher]
	Evaluation of superficial xenograft volume estimation by ultrasound and caliper against MRI in a longitudinal pre-clinical radiotherapeutic setting. PLoS One Roth D, Safi M, Vilhelmsson Timmermand O, Sereti E, Molendowska M, Gottschalk M, Bjartell A, Ceberg C, Szczepankiewicz F, Strand J. PMID: 39052663 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 169642

Seite 1 von 8483



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung